Structure

Physi-Chem Properties

Molecular Weight:  464.22
Volume:  487.631
LogP:  6.623
LogD:  3.821
LogS:  -2.106
# Rotatable Bonds:  5
TPSA:  100.13
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.332
Synthetic Accessibility Score:  3.83
Fsp3:  0.393
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.831
MDCK Permeability:  1.4945566363167018e-05
Pgp-inhibitor:  0.824
Pgp-substrate:  0.987
Human Intestinal Absorption (HIA):  0.056
20% Bioavailability (F20%):  0.62
30% Bioavailability (F30%):  0.009

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.012
Plasma Protein Binding (PPB):  94.7146987915039%
Volume Distribution (VD):  0.367
Pgp-substrate:  3.8510055541992188%

ADMET: Metabolism

CYP1A2-inhibitor:  0.362
CYP1A2-substrate:  0.321
CYP2C19-inhibitor:  0.684
CYP2C19-substrate:  0.077
CYP2C9-inhibitor:  0.837
CYP2C9-substrate:  0.947
CYP2D6-inhibitor:  0.47
CYP2D6-substrate:  0.228
CYP3A4-inhibitor:  0.222
CYP3A4-substrate:  0.114

ADMET: Excretion

Clearance (CL):  4.621
Half-life (T1/2):  0.187

ADMET: Toxicity

hERG Blockers:  0.037
Human Hepatotoxicity (H-HT):  0.973
Drug-inuced Liver Injury (DILI):  0.562
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.94
Maximum Recommended Daily Dose:  0.962
Skin Sensitization:  0.764
Carcinogencity:  0.15
Eye Corrosion:  0.003
Eye Irritation:  0.051
Respiratory Toxicity:  0.728

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC3629

Natural Product ID:  NPC3629
Common Name*:   Cochinensoxanthone
IUPAC Name:   (3S)-6-[(2E)-3,7-dimethylocta-2,6-dienyl]-3,5,10-trihydroxy-2,2-dimethyl-3,4-dihydropyrano[2,3-a]xanthen-12-one
Synonyms:   Cochinensoxanthone
Standard InCHIKey:  GZOFBXLMLDTZJM-NAVGAYGYSA-N
Standard InCHI:  InChI=1S/C28H32O6/c1-15(2)7-6-8-16(3)9-11-18-24(31)20-14-22(30)28(4,5)34-27(20)23-25(32)19-13-17(29)10-12-21(19)33-26(18)23/h7,9-10,12-13,22,29-31H,6,8,11,14H2,1-5H3/b16-9+/t22-/m0/s1
SMILES:  C/C(=CCc1c(O)c2C[C@H](O)C(Oc2c2c1oc1ccc(cc1c2=O)O)(C)C)/CCC=C(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1782239
PubChem CID:   53355018
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003518] 4-prenylated xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24928 Cratoxylum cochinchinense Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[15182859]
NPO24928 Cratoxylum cochinchinense Species Hypericaceae Eukaryota n.a. root n.a. PMID[16310231]
NPO24928 Cratoxylum cochinchinense Species Hypericaceae Eukaryota n.a. root n.a. PMID[16651783]
NPO24928 Cratoxylum cochinchinense Species Hypericaceae Eukaryota n.a. stem n.a. PMID[21428375]
NPO24928 Cratoxylum cochinchinense Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24928 Cratoxylum cochinchinense Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24928 Cratoxylum cochinchinense Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell Line HT-29 Homo sapiens ED50 > 10.0 uM PMID[451940]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC3629 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9934 High Similarity NPC471976
0.9671 High Similarity NPC477958
0.9539 High Similarity NPC475790
0.9481 High Similarity NPC78492
0.9481 High Similarity NPC208152
0.9477 High Similarity NPC7989
0.9477 High Similarity NPC223701
0.9477 High Similarity NPC472583
0.9477 High Similarity NPC469405
0.9474 High Similarity NPC471676
0.9474 High Similarity NPC472422
0.9474 High Similarity NPC244577
0.9474 High Similarity NPC471677
0.9474 High Similarity NPC474021
0.9474 High Similarity NPC472420
0.9474 High Similarity NPC474023
0.9474 High Similarity NPC263384
0.9427 High Similarity NPC220912
0.9427 High Similarity NPC474034
0.9427 High Similarity NPC474033
0.9363 High Similarity NPC134783
0.9363 High Similarity NPC228383
0.9363 High Similarity NPC472632
0.9363 High Similarity NPC471210
0.9359 High Similarity NPC473990
0.9351 High Similarity NPC293286
0.9342 High Similarity NPC266499
0.9342 High Similarity NPC223988
0.9342 High Similarity NPC472628
0.9317 High Similarity NPC103307
0.9313 High Similarity NPC225419
0.9313 High Similarity NPC6588
0.9313 High Similarity NPC477154
0.9313 High Similarity NPC117854
0.9308 High Similarity NPC234052
0.9304 High Similarity NPC472402
0.9304 High Similarity NPC473961
0.9304 High Similarity NPC472448
0.9304 High Similarity NPC83922
0.9299 High Similarity NPC174953
0.9299 High Similarity NPC475784
0.9295 High Similarity NPC471209
0.929 High Similarity NPC304207
0.929 High Similarity NPC259710
0.929 High Similarity NPC477530
0.929 High Similarity NPC48579
0.929 High Similarity NPC217706
0.929 High Similarity NPC470681
0.929 High Similarity NPC207809
0.9286 High Similarity NPC161881
0.9286 High Similarity NPC171651
0.9286 High Similarity NPC35567
0.9286 High Similarity NPC477957
0.9286 High Similarity NPC56232
0.9286 High Similarity NPC243171
0.9286 High Similarity NPC473996
0.9286 High Similarity NPC150123
0.9286 High Similarity NPC244583
0.9286 High Similarity NPC138288
0.9286 High Similarity NPC10807
0.9281 High Similarity NPC37348
0.9281 High Similarity NPC472633
0.9281 High Similarity NPC101957
0.9281 High Similarity NPC120105
0.9276 High Similarity NPC186397
0.9276 High Similarity NPC37135
0.9259 High Similarity NPC121333
0.9255 High Similarity NPC152477
0.925 High Similarity NPC128293
0.925 High Similarity NPC471213
0.925 High Similarity NPC120593
0.925 High Similarity NPC173292
0.9245 High Similarity NPC124038
0.9241 High Similarity NPC471211
0.9241 High Similarity NPC74854
0.9241 High Similarity NPC474038
0.9241 High Similarity NPC472634
0.9241 High Similarity NPC30655
0.9241 High Similarity NPC167678
0.9241 High Similarity NPC29876
0.9241 High Similarity NPC471212
0.9241 High Similarity NPC45124
0.9236 High Similarity NPC250214
0.9236 High Similarity NPC95936
0.9231 High Similarity NPC215917
0.9231 High Similarity NPC10754
0.9231 High Similarity NPC20530
0.9226 High Similarity NPC326592
0.9226 High Similarity NPC248793
0.9226 High Similarity NPC180301
0.9226 High Similarity NPC209760
0.9226 High Similarity NPC203080
0.9226 High Similarity NPC112701
0.9226 High Similarity NPC109594
0.9226 High Similarity NPC100134
0.9221 High Similarity NPC262039
0.9221 High Similarity NPC262038
0.9221 High Similarity NPC477897
0.9221 High Similarity NPC472580
0.9221 High Similarity NPC474772
0.9221 High Similarity NPC254412
0.9221 High Similarity NPC474744
0.9221 High Similarity NPC472636
0.9221 High Similarity NPC289774
0.9221 High Similarity NPC328740
0.9221 High Similarity NPC472423
0.9221 High Similarity NPC278476
0.9221 High Similarity NPC319910
0.9221 High Similarity NPC209846
0.9216 High Similarity NPC89442
0.9211 High Similarity NPC472627
0.9211 High Similarity NPC91902
0.9198 High Similarity NPC74559
0.9193 High Similarity NPC8965
0.9193 High Similarity NPC14662
0.9187 High Similarity NPC50960
0.9187 High Similarity NPC293319
0.9187 High Similarity NPC224280
0.9187 High Similarity NPC62261
0.9182 High Similarity NPC476247
0.9182 High Similarity NPC261470
0.9177 High Similarity NPC118256
0.9177 High Similarity NPC204290
0.9177 High Similarity NPC472631
0.9177 High Similarity NPC472630
0.9177 High Similarity NPC476980
0.9177 High Similarity NPC192686
0.9177 High Similarity NPC119209
0.9172 High Similarity NPC474055
0.9172 High Similarity NPC196448
0.9172 High Similarity NPC476981
0.9172 High Similarity NPC223787
0.9172 High Similarity NPC99597
0.9172 High Similarity NPC282390
0.9172 High Similarity NPC162869
0.9172 High Similarity NPC27337
0.9172 High Similarity NPC48208
0.9172 High Similarity NPC281137
0.9172 High Similarity NPC475267
0.9172 High Similarity NPC262286
0.9172 High Similarity NPC36852
0.9172 High Similarity NPC78225
0.9172 High Similarity NPC474208
0.9172 High Similarity NPC156057
0.9172 High Similarity NPC284820
0.9172 High Similarity NPC473272
0.9172 High Similarity NPC291508
0.9172 High Similarity NPC210084
0.9172 High Similarity NPC472598
0.9172 High Similarity NPC474836
0.9167 High Similarity NPC111341
0.9167 High Similarity NPC476169
0.9167 High Similarity NPC37392
0.9167 High Similarity NPC304745
0.9167 High Similarity NPC113906
0.9167 High Similarity NPC226025
0.9167 High Similarity NPC321779
0.9161 High Similarity NPC474843
0.9161 High Similarity NPC216035
0.9161 High Similarity NPC327269
0.9161 High Similarity NPC285623
0.9161 High Similarity NPC210597
0.9161 High Similarity NPC31627
0.9161 High Similarity NPC476238
0.9161 High Similarity NPC217149
0.9156 High Similarity NPC472421
0.9156 High Similarity NPC177308
0.9156 High Similarity NPC124478
0.9156 High Similarity NPC105136
0.915 High Similarity NPC160821
0.915 High Similarity NPC132592
0.9145 High Similarity NPC290133
0.9145 High Similarity NPC187282
0.9145 High Similarity NPC24136
0.9145 High Similarity NPC472629
0.9145 High Similarity NPC316769
0.9141 High Similarity NPC212038
0.9141 High Similarity NPC271848
0.9141 High Similarity NPC81332
0.9141 High Similarity NPC262580
0.9141 High Similarity NPC289396
0.9136 High Similarity NPC177480
0.9136 High Similarity NPC242395
0.9136 High Similarity NPC326877
0.913 High Similarity NPC39091
0.913 High Similarity NPC119589
0.913 High Similarity NPC70441
0.9125 High Similarity NPC152659
0.9125 High Similarity NPC472625
0.9125 High Similarity NPC236521
0.9125 High Similarity NPC248638
0.9125 High Similarity NPC7483
0.9125 High Similarity NPC273959
0.9119 High Similarity NPC474186
0.9119 High Similarity NPC142252
0.9119 High Similarity NPC26326
0.9119 High Similarity NPC308992
0.9119 High Similarity NPC198829
0.9119 High Similarity NPC266314
0.9119 High Similarity NPC474187

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC3629 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9156 High Similarity NPD4380 Phase 2
0.9103 High Similarity NPD2393 Clinical (unspecified phase)
0.8938 High Similarity NPD5494 Approved
0.8931 High Similarity NPD7075 Discontinued
0.8917 High Similarity NPD1934 Approved
0.8861 High Similarity NPD2801 Approved
0.8861 High Similarity NPD7096 Clinical (unspecified phase)
0.8834 High Similarity NPD6166 Phase 2
0.8834 High Similarity NPD6168 Clinical (unspecified phase)
0.8834 High Similarity NPD6167 Clinical (unspecified phase)
0.8812 High Similarity NPD4381 Clinical (unspecified phase)
0.8788 High Similarity NPD7804 Clinical (unspecified phase)
0.8735 High Similarity NPD7074 Phase 3
0.871 High Similarity NPD4378 Clinical (unspecified phase)
0.8688 High Similarity NPD8443 Clinical (unspecified phase)
0.8684 High Similarity NPD1549 Phase 2
0.8675 High Similarity NPD7054 Approved
0.8625 High Similarity NPD7819 Suspended
0.8623 High Similarity NPD7472 Approved
0.8618 High Similarity NPD1552 Clinical (unspecified phase)
0.8618 High Similarity NPD1550 Clinical (unspecified phase)
0.859 High Similarity NPD7410 Clinical (unspecified phase)
0.8571 High Similarity NPD5402 Approved
0.8562 High Similarity NPD6801 Discontinued
0.8537 High Similarity NPD6959 Discontinued
0.8521 High Similarity NPD7251 Discontinued
0.8519 High Similarity NPD3882 Suspended
0.8519 High Similarity NPD4868 Clinical (unspecified phase)
0.8503 High Similarity NPD3818 Discontinued
0.85 High Similarity NPD7411 Suspended
0.8471 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8471 Intermediate Similarity NPD7808 Phase 3
0.8462 Intermediate Similarity NPD6797 Phase 2
0.8452 Intermediate Similarity NPD5844 Phase 1
0.8431 Intermediate Similarity NPD2796 Approved
0.8412 Intermediate Similarity NPD6559 Discontinued
0.8408 Intermediate Similarity NPD1511 Approved
0.8366 Intermediate Similarity NPD1510 Phase 2
0.8302 Intermediate Similarity NPD1512 Approved
0.8295 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8291 Intermediate Similarity NPD6799 Approved
0.8246 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8232 Intermediate Similarity NPD3817 Phase 2
0.8224 Intermediate Similarity NPD1240 Approved
0.8194 Intermediate Similarity NPD2935 Discontinued
0.8182 Intermediate Similarity NPD7768 Phase 2
0.8166 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD5403 Approved
0.8118 Intermediate Similarity NPD7473 Discontinued
0.8117 Intermediate Similarity NPD1607 Approved
0.8098 Intermediate Similarity NPD6599 Discontinued
0.8047 Intermediate Similarity NPD6232 Discontinued
0.8024 Intermediate Similarity NPD3749 Approved
0.8012 Intermediate Similarity NPD5401 Approved
0.8 Intermediate Similarity NPD8312 Approved
0.8 Intermediate Similarity NPD8313 Approved
0.7988 Intermediate Similarity NPD1247 Approved
0.7965 Intermediate Similarity NPD3751 Discontinued
0.7952 Intermediate Similarity NPD1465 Phase 2
0.7925 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD2800 Approved
0.7901 Intermediate Similarity NPD2532 Approved
0.7901 Intermediate Similarity NPD2534 Approved
0.7901 Intermediate Similarity NPD2533 Approved
0.788 Intermediate Similarity NPD6778 Approved
0.788 Intermediate Similarity NPD6781 Approved
0.788 Intermediate Similarity NPD6779 Approved
0.788 Intermediate Similarity NPD6780 Approved
0.788 Intermediate Similarity NPD6777 Approved
0.788 Intermediate Similarity NPD6782 Approved
0.788 Intermediate Similarity NPD6776 Approved
0.7875 Intermediate Similarity NPD4628 Phase 3
0.7875 Intermediate Similarity NPD3750 Approved
0.7849 Intermediate Similarity NPD7697 Approved
0.7849 Intermediate Similarity NPD7696 Phase 3
0.7849 Intermediate Similarity NPD7435 Discontinued
0.7849 Intermediate Similarity NPD7698 Approved
0.7836 Intermediate Similarity NPD3787 Discontinued
0.7816 Intermediate Similarity NPD7286 Phase 2
0.7805 Intermediate Similarity NPD920 Approved
0.7784 Intermediate Similarity NPD6844 Discontinued
0.7778 Intermediate Similarity NPD7701 Phase 2
0.7778 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD8150 Discontinued
0.7756 Intermediate Similarity NPD1613 Approved
0.7756 Intermediate Similarity NPD943 Approved
0.7756 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7749 Intermediate Similarity NPD7783 Phase 2
0.7749 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD6099 Approved
0.7736 Intermediate Similarity NPD6100 Approved
0.7736 Intermediate Similarity NPD1551 Phase 2
0.7727 Intermediate Similarity NPD5953 Discontinued
0.7725 Intermediate Similarity NPD7584 Approved
0.7717 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7713 Intermediate Similarity NPD7871 Phase 2
0.7713 Intermediate Similarity NPD7870 Phase 2
0.7711 Intermediate Similarity NPD3226 Approved
0.7701 Intermediate Similarity NPD6823 Phase 2
0.7688 Intermediate Similarity NPD2346 Discontinued
0.7683 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD7699 Phase 2
0.7676 Intermediate Similarity NPD7700 Phase 2
0.7673 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD2799 Discontinued
0.7667 Intermediate Similarity NPD8434 Phase 2
0.7661 Intermediate Similarity NPD919 Approved
0.7658 Intermediate Similarity NPD6651 Approved
0.7654 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD8151 Discontinued
0.764 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD2313 Discontinued
0.7611 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD6534 Approved
0.7609 Intermediate Similarity NPD4363 Phase 3
0.7609 Intermediate Similarity NPD4360 Phase 2
0.7609 Intermediate Similarity NPD6535 Approved
0.7604 Intermediate Similarity NPD7874 Approved
0.7604 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD1243 Approved
0.7586 Intermediate Similarity NPD3926 Phase 2
0.7578 Intermediate Similarity NPD2344 Approved
0.7565 Intermediate Similarity NPD7801 Approved
0.7562 Intermediate Similarity NPD3748 Approved
0.7561 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD2424 Discontinued
0.7529 Intermediate Similarity NPD8455 Phase 2
0.7515 Intermediate Similarity NPD7390 Discontinued
0.7515 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6190 Approved
0.75 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4908 Phase 1
0.7484 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD5124 Phase 1
0.7484 Intermediate Similarity NPD230 Phase 1
0.747 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD7228 Approved
0.7453 Intermediate Similarity NPD7033 Discontinued
0.7452 Intermediate Similarity NPD3027 Phase 3
0.744 Intermediate Similarity NPD1653 Approved
0.7436 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD5711 Approved
0.7429 Intermediate Similarity NPD5710 Approved
0.7396 Intermediate Similarity NPD7458 Discontinued
0.7394 Intermediate Similarity NPD2309 Approved
0.7389 Intermediate Similarity NPD7685 Pre-registration
0.7389 Intermediate Similarity NPD6832 Phase 2
0.7381 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD447 Suspended
0.7344 Intermediate Similarity NPD8319 Approved
0.7344 Intermediate Similarity NPD8320 Phase 1
0.7342 Intermediate Similarity NPD4625 Phase 3
0.7333 Intermediate Similarity NPD3823 Discontinued
0.733 Intermediate Similarity NPD7229 Phase 3
0.7326 Intermediate Similarity NPD5761 Phase 2
0.7326 Intermediate Similarity NPD5760 Phase 2
0.7325 Intermediate Similarity NPD2861 Phase 2
0.732 Intermediate Similarity NPD7585 Approved
0.7308 Intermediate Similarity NPD1203 Approved
0.7296 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6212 Phase 3
0.7273 Intermediate Similarity NPD6213 Phase 3
0.7273 Intermediate Similarity NPD1610 Phase 2
0.7273 Intermediate Similarity NPD7199 Phase 2
0.7273 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7583 Approved
0.7267 Intermediate Similarity NPD37 Approved
0.7267 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD6234 Discontinued
0.725 Intermediate Similarity NPD6233 Phase 2
0.7241 Intermediate Similarity NPD4967 Phase 2
0.7241 Intermediate Similarity NPD4965 Approved
0.7241 Intermediate Similarity NPD4966 Approved
0.7239 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD4361 Phase 2
0.7188 Intermediate Similarity NPD6798 Discontinued
0.7169 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD1652 Phase 2
0.716 Intermediate Similarity NPD4662 Approved
0.716 Intermediate Similarity NPD4661 Approved
0.716 Intermediate Similarity NPD6355 Discontinued
0.716 Intermediate Similarity NPD1933 Approved
0.7152 Intermediate Similarity NPD7266 Discontinued
0.7152 Intermediate Similarity NPD2798 Approved
0.7151 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4308 Phase 3
0.7124 Intermediate Similarity NPD1548 Phase 1
0.7118 Intermediate Similarity NPD6273 Approved
0.7115 Intermediate Similarity NPD9717 Approved
0.7112 Intermediate Similarity NPD4287 Approved
0.7107 Intermediate Similarity NPD9494 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data